akash.verma@cenmed.com
(732) 447-1115-
A14427-0BFormula: C8H7N Formula weight: 117.15 Purity: 99% CAS Number: 120-72-9 UN Number: UN2811 Hazard Class: 6. -
135340-10GCAS: 10294-64-1 EC No: 233-665-2 MDL No: MFCD00043089 UN No: UN1479 Haz Class: 5.1 Packing Group: III Powder Molecular Formula: K<sub>2</sub>MnO<sub>4</sub> MW: 197.13 Melting Point: 190° -
44-660KMG44-660KMG 10-Plex Hu MAPK/SAPK Phospho Biotin 20x -
-
-
-
-
SML2971-25MGBiochem/physiol Actions K03861 is an ATP site-binding, cyclin-competitive, type II CDK2 inhibitor that selectively targets and locks the kinase in its inactive DFG-out conformation (CDK2 Kd = 50 nM, DFG-out stabilizing CDK2-C118L/A144C mutant Kd = -
SML2971-5MGBiochem/physiol Actions K03861 is an ATP site-binding, cyclin-competitive, type II CDK2 inhibitor that selectively targets and locks the kinase in its inactive DFG-out conformation (CDK2 Kd = 50 nM, DFG-out stabilizing CDK2-C118L/A144C mutant Kd = -
K647391-5mgKS106 is a potent ALDH inhibitor with IC 50 s of 334, 2137, 360 nM for ALDH1A1, ALDH2 , and ALDH3A1, respectively. KS106 shows antiproliferative and anticancer effects with low low toxic.KS106 significantly increases ROS activity, lipid peroxidation -
K647391-50mgKS106 is a potent ALDH inhibitor with IC 50 s of 334, 2137, 360 nM for ALDH1A1, ALDH2 , and ALDH3A1, respectively. KS106 shows antiproliferative and anticancer effects with low low toxic.KS106 significantly increases ROS activity, lipid peroxidation -
K647391-25mgKS106 is a potent ALDH inhibitor with IC 50 s of 334, 2137, 360 nM for ALDH1A1, ALDH2 , and ALDH3A1, respectively. KS106 shows antiproliferative and anticancer effects with low low toxic.KS106 significantly increases ROS activity, lipid peroxidation
